nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—MPO—hematologic cancer	0.234	1	CbGaD
Ticlopidine—MPO—Cisplatin—hematologic cancer	0.0206	0.0397	CbGbCtD
Ticlopidine—CYP1A2—Anagrelide—hematologic cancer	0.017	0.0326	CbGbCtD
Ticlopidine—CYP1A1—Methoxsalen—hematologic cancer	0.017	0.0326	CbGbCtD
Ticlopidine—CYP2B6—Thiotepa—hematologic cancer	0.0166	0.032	CbGbCtD
Ticlopidine—CYP1A1—Bortezomib—hematologic cancer	0.0161	0.031	CbGbCtD
Ticlopidine—CYP1A1—Daunorubicin—hematologic cancer	0.0154	0.0297	CbGbCtD
Ticlopidine—CYP1A1—Thalidomide—hematologic cancer	0.014	0.027	CbGbCtD
Ticlopidine—CYP1A1—Dacarbazine—hematologic cancer	0.0121	0.0232	CbGbCtD
Ticlopidine—CYP2E1—Thalidomide—hematologic cancer	0.0109	0.0209	CbGbCtD
Ticlopidine—CYP2C9—Bexarotene—hematologic cancer	0.0106	0.0204	CbGbCtD
Ticlopidine—CYP1A1—Dasatinib—hematologic cancer	0.00949	0.0183	CbGbCtD
Ticlopidine—CYP2B6—Ifosfamide—hematologic cancer	0.00942	0.0181	CbGbCtD
Ticlopidine—CYP2E1—Dacarbazine—hematologic cancer	0.00933	0.018	CbGbCtD
Ticlopidine—CYP2C8—Bortezomib—hematologic cancer	0.00931	0.0179	CbGbCtD
Ticlopidine—CYP2D6—Lomustine—hematologic cancer	0.009	0.0173	CbGbCtD
Ticlopidine—CYP1A2—Carmustine—hematologic cancer	0.00891	0.0171	CbGbCtD
Ticlopidine—CYP2C9—Idarubicin—hematologic cancer	0.00878	0.0169	CbGbCtD
Ticlopidine—CYP2B6—Nilotinib—hematologic cancer	0.00818	0.0157	CbGbCtD
Ticlopidine—CYP2D6—Idarubicin—hematologic cancer	0.00802	0.0154	CbGbCtD
Ticlopidine—CYP2C19—Bortezomib—hematologic cancer	0.00781	0.015	CbGbCtD
Ticlopidine—CYP1A2—Methoxsalen—hematologic cancer	0.00757	0.0146	CbGbCtD
Ticlopidine—CYP2E1—Mitoxantrone—hematologic cancer	0.00724	0.0139	CbGbCtD
Ticlopidine—CYP1A2—Bortezomib—hematologic cancer	0.0072	0.0139	CbGbCtD
Ticlopidine—CYP2C8—Ifosfamide—hematologic cancer	0.00714	0.0137	CbGbCtD
Ticlopidine—CYP1A2—Daunorubicin—hematologic cancer	0.00689	0.0133	CbGbCtD
Ticlopidine—CYP2D6—Hydroxyurea—hematologic cancer	0.00682	0.0131	CbGbCtD
Ticlopidine—CYP2C19—Thalidomide—hematologic cancer	0.0068	0.0131	CbGbCtD
Ticlopidine—CYP1A2—Alitretinoin—hematologic cancer	0.00675	0.013	CbGbCtD
Ticlopidine—CYP2C9—Bortezomib—hematologic cancer	0.00649	0.0125	CbGbCtD
Ticlopidine—CYP2C19—Teniposide—hematologic cancer	0.00649	0.0125	CbGbCtD
Ticlopidine—CYP1A2—Thalidomide—hematologic cancer	0.00628	0.0121	CbGbCtD
Ticlopidine—CYP2C8—Nilotinib—hematologic cancer	0.0062	0.0119	CbGbCtD
Ticlopidine—CYP3A4—Bexarotene—hematologic cancer	0.00616	0.0118	CbGbCtD
Ticlopidine—CYP2C19—Ifosfamide—hematologic cancer	0.00599	0.0115	CbGbCtD
Ticlopidine—CYP2D6—Bortezomib—hematologic cancer	0.00594	0.0114	CbGbCtD
Ticlopidine—CYP3A4—Lomustine—hematologic cancer	0.00573	0.011	CbGbCtD
Ticlopidine—CYP3A4—Busulfan—hematologic cancer	0.00573	0.011	CbGbCtD
Ticlopidine—CYP2C19—Imatinib—hematologic cancer	0.00572	0.011	CbGbCtD
Ticlopidine—CYP2C9—Thalidomide—hematologic cancer	0.00566	0.0109	CbGbCtD
Ticlopidine—CYP2B6—Irinotecan—hematologic cancer	0.00562	0.0108	CbGbCtD
Ticlopidine—CYP1A2—Dacarbazine—hematologic cancer	0.0054	0.0104	CbGbCtD
Ticlopidine—CYP2C9—Teniposide—hematologic cancer	0.00539	0.0104	CbGbCtD
Ticlopidine—CYP1A2—Imatinib—hematologic cancer	0.00528	0.0102	CbGbCtD
Ticlopidine—CYP3A4—Thiotepa—hematologic cancer	0.0051	0.00982	CbGbCtD
Ticlopidine—CYP2C9—Ifosfamide—hematologic cancer	0.00498	0.00958	CbGbCtD
Ticlopidine—CYP1A1—Dexamethasone—hematologic cancer	0.00486	0.00935	CbGbCtD
Ticlopidine—CYP2C9—Imatinib—hematologic cancer	0.00476	0.00915	CbGbCtD
Ticlopidine—CYP2B6—Cisplatin—hematologic cancer	0.00458	0.00882	CbGbCtD
Ticlopidine—CYP2E1—Etoposide—hematologic cancer	0.00457	0.00878	CbGbCtD
Ticlopidine—CYP2D6—Imatinib—hematologic cancer	0.00435	0.00837	CbGbCtD
Ticlopidine—CYP2C9—Nilotinib—hematologic cancer	0.00432	0.00831	CbGbCtD
Ticlopidine—CYP1A2—Dasatinib—hematologic cancer	0.00424	0.00816	CbGbCtD
Ticlopidine—CYP3A4—Methoxsalen—hematologic cancer	0.00397	0.00763	CbGbCtD
Ticlopidine—CYP2D6—Nilotinib—hematologic cancer	0.00395	0.0076	CbGbCtD
Ticlopidine—CYP2D6—Vinorelbine—hematologic cancer	0.00392	0.00754	CbGbCtD
Ticlopidine—CYP3A4—Bortezomib—hematologic cancer	0.00377	0.00726	CbGbCtD
Ticlopidine—CYP2C19—Prednisone—hematologic cancer	0.00377	0.00725	CbGbCtD
Ticlopidine—CYP2E1—Dexamethasone—hematologic cancer	0.00375	0.00722	CbGbCtD
Ticlopidine—CYP2B6—Dexamethasone—hematologic cancer	0.0037	0.00712	CbGbCtD
Ticlopidine—CYP3A4—Daunorubicin—hematologic cancer	0.00361	0.00694	CbGbCtD
Ticlopidine—CYP2C8—Etoposide—hematologic cancer	0.00341	0.00656	CbGbCtD
Ticlopidine—CYP3A4—Cytarabine—hematologic cancer	0.00318	0.00613	CbGbCtD
Ticlopidine—CYP3A4—Teniposide—hematologic cancer	0.00314	0.00603	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—hematologic cancer	0.00307	0.00591	CbGbCtD
Ticlopidine—CYP3A4—Ifosfamide—hematologic cancer	0.00289	0.00557	CbGbCtD
Ticlopidine—CYP2C8—Dexamethasone—hematologic cancer	0.0028	0.0054	CbGbCtD
Ticlopidine—CYP3A4—Imatinib—hematologic cancer	0.00277	0.00532	CbGbCtD
Ticlopidine—CYP1A2—Etoposide—hematologic cancer	0.00264	0.00508	CbGbCtD
Ticlopidine—CYP3A4—Ruxolitinib—hematologic cancer	0.0026	0.00501	CbGbCtD
Ticlopidine—CYP3A4—Nilotinib—hematologic cancer	0.00251	0.00483	CbGbCtD
Ticlopidine—CYP3A4—Vinorelbine—hematologic cancer	0.00249	0.00479	CbGbCtD
Ticlopidine—CYP2C9—Cisplatin—hematologic cancer	0.00242	0.00466	CbGbCtD
Ticlopidine—CYP2D6—Vinblastine—hematologic cancer	0.00242	0.00465	CbGbCtD
Ticlopidine—CYP2C19—Dexamethasone—hematologic cancer	0.00235	0.00453	CbGbCtD
Ticlopidine—CYP3A4—Triamcinolone—hematologic cancer	0.00228	0.00438	CbGbCtD
Ticlopidine—P2RY12—hematopoietic system—hematologic cancer	0.00226	0.125	CbGeAlD
Ticlopidine—CYP3A4—Dasatinib—hematologic cancer	0.00222	0.00427	CbGbCtD
Ticlopidine—CYP3A4—Mitoxantrone—hematologic cancer	0.00219	0.00422	CbGbCtD
Ticlopidine—CYP2C9—Dexamethasone—hematologic cancer	0.00196	0.00376	CbGbCtD
Ticlopidine—CYP3A4—Betamethasone—hematologic cancer	0.00196	0.00376	CbGbCtD
Ticlopidine—CYP3A4—Prednisolone—hematologic cancer	0.00193	0.00371	CbGbCtD
Ticlopidine—CYP3A4—Prednisone—hematologic cancer	0.00182	0.00351	CbGbCtD
Ticlopidine—CYP2D6—Dexamethasone—hematologic cancer	0.00179	0.00344	CbGbCtD
Ticlopidine—CYP3A4—Irinotecan—hematologic cancer	0.00173	0.00332	CbGbCtD
Ticlopidine—CYP3A4—Vinblastine—hematologic cancer	0.00154	0.00295	CbGbCtD
Ticlopidine—CYP3A4—Vincristine—hematologic cancer	0.00151	0.0029	CbGbCtD
Ticlopidine—P2RY12—blood—hematologic cancer	0.0015	0.0825	CbGeAlD
Ticlopidine—CYP2D6—Doxorubicin—hematologic cancer	0.00148	0.00285	CbGbCtD
Ticlopidine—CYP3A4—Etoposide—hematologic cancer	0.00138	0.00266	CbGbCtD
Ticlopidine—CYP3A4—Dexamethasone—hematologic cancer	0.00114	0.00219	CbGbCtD
Ticlopidine—MPO—hematopoietic system—hematologic cancer	0.000992	0.0546	CbGeAlD
Ticlopidine—CYP3A4—Doxorubicin—hematologic cancer	0.000944	0.00182	CbGbCtD
Ticlopidine—CYP2C19—hematopoietic system—hematologic cancer	0.000665	0.0366	CbGeAlD
Ticlopidine—MPO—blood—hematologic cancer	0.000657	0.0362	CbGeAlD
Ticlopidine—MPO—bone marrow—hematologic cancer	0.000636	0.035	CbGeAlD
Ticlopidine—CYP2C8—hematopoietic system—hematologic cancer	0.00058	0.032	CbGeAlD
Ticlopidine—MPO—lung—hematologic cancer	0.000576	0.0317	CbGeAlD
Ticlopidine—MPO—testis—hematologic cancer	0.000543	0.0299	CbGeAlD
Ticlopidine—CYP1A2—hematopoietic system—hematologic cancer	0.000543	0.0299	CbGeAlD
Ticlopidine—CYP1A1—hematopoietic system—hematologic cancer	0.000535	0.0295	CbGeAlD
Ticlopidine—CYP2B6—hematopoietic system—hematologic cancer	0.00052	0.0287	CbGeAlD
Ticlopidine—CYP2C9—hematopoietic system—hematologic cancer	0.000515	0.0284	CbGeAlD
Ticlopidine—CYP2E1—hematopoietic system—hematologic cancer	0.000488	0.0269	CbGeAlD
Ticlopidine—CYP2C19—blood—hematologic cancer	0.00044	0.0243	CbGeAlD
Ticlopidine—CYP2B6—gonad—hematologic cancer	0.000396	0.0218	CbGeAlD
Ticlopidine—MPO—lymph node—hematologic cancer	0.000394	0.0217	CbGeAlD
Ticlopidine—CYP3A4—hematopoietic system—hematologic cancer	0.000393	0.0217	CbGeAlD
Ticlopidine—CYP2D6—hematopoietic system—hematologic cancer	0.000387	0.0213	CbGeAlD
Ticlopidine—CYP2C8—blood—hematologic cancer	0.000384	0.0212	CbGeAlD
Ticlopidine—CYP1A2—blood—hematologic cancer	0.00036	0.0198	CbGeAlD
Ticlopidine—CYP1A1—blood—hematologic cancer	0.000355	0.0195	CbGeAlD
Ticlopidine—CYP2B6—blood—hematologic cancer	0.000345	0.019	CbGeAlD
Ticlopidine—CYP2C9—blood—hematologic cancer	0.000341	0.0188	CbGeAlD
Ticlopidine—CYP2E1—blood—hematologic cancer	0.000324	0.0178	CbGeAlD
Ticlopidine—CYP2C8—testis—hematologic cancer	0.000318	0.0175	CbGeAlD
Ticlopidine—CYP1A2—lung—hematologic cancer	0.000315	0.0174	CbGeAlD
Ticlopidine—CYP1A1—lung—hematologic cancer	0.000311	0.0171	CbGeAlD
Ticlopidine—CYP2B6—lung—hematologic cancer	0.000302	0.0167	CbGeAlD
Ticlopidine—CYP2B6—testis—hematologic cancer	0.000285	0.0157	CbGeAlD
Ticlopidine—CYP2E1—lung—hematologic cancer	0.000284	0.0156	CbGeAlD
Ticlopidine—CYP2E1—testis—hematologic cancer	0.000268	0.0147	CbGeAlD
Ticlopidine—CYP3A4—blood—hematologic cancer	0.00026	0.0143	CbGeAlD
Ticlopidine—CYP2D6—blood—hematologic cancer	0.000256	0.0141	CbGeAlD
Ticlopidine—CYP1A1—lymph node—hematologic cancer	0.000213	0.0117	CbGeAlD
Ticlopidine—CYP2D6—testis—hematologic cancer	0.000212	0.0117	CbGeAlD
Ticlopidine—Clopidogrel—ABCB1—hematologic cancer	8.46e-05	1	CrCbGaD
Ticlopidine—Asthenia—Mitoxantrone—hematologic cancer	3.97e-05	0.000236	CcSEcCtD
Ticlopidine—Asthenia—Irinotecan—hematologic cancer	3.97e-05	0.000236	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—hematologic cancer	3.96e-05	0.000235	CcSEcCtD
Ticlopidine—Myalgia—Dexamethasone—hematologic cancer	3.95e-05	0.000234	CcSEcCtD
Ticlopidine—Myalgia—Betamethasone—hematologic cancer	3.95e-05	0.000234	CcSEcCtD
Ticlopidine—Vomiting—Thalidomide—hematologic cancer	3.94e-05	0.000234	CcSEcCtD
Ticlopidine—Dizziness—Carmustine—hematologic cancer	3.93e-05	0.000234	CcSEcCtD
Ticlopidine—Pain—Etoposide—hematologic cancer	3.93e-05	0.000234	CcSEcCtD
Ticlopidine—Rash—Thalidomide—hematologic cancer	3.9e-05	0.000232	CcSEcCtD
Ticlopidine—Dermatitis—Thalidomide—hematologic cancer	3.9e-05	0.000232	CcSEcCtD
Ticlopidine—Haemoglobin—Methotrexate—hematologic cancer	3.9e-05	0.000231	CcSEcCtD
Ticlopidine—Dizziness—Alitretinoin—hematologic cancer	3.9e-05	0.000231	CcSEcCtD
Ticlopidine—Diarrhoea—Vincristine—hematologic cancer	3.88e-05	0.000231	CcSEcCtD
Ticlopidine—Headache—Thalidomide—hematologic cancer	3.88e-05	0.00023	CcSEcCtD
Ticlopidine—Pain—Prednisolone—hematologic cancer	3.88e-05	0.00023	CcSEcCtD
Ticlopidine—Haemorrhage—Methotrexate—hematologic cancer	3.88e-05	0.00023	CcSEcCtD
Ticlopidine—Hepatitis—Methotrexate—hematologic cancer	3.88e-05	0.00023	CcSEcCtD
Ticlopidine—Asthenia—Gemcitabine—hematologic cancer	3.86e-05	0.000229	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—hematologic cancer	3.85e-05	0.000229	CcSEcCtD
Ticlopidine—Dizziness—Ifosfamide—hematologic cancer	3.85e-05	0.000229	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—hematologic cancer	3.81e-05	0.000226	CcSEcCtD
Ticlopidine—Pruritus—Gemcitabine—hematologic cancer	3.81e-05	0.000226	CcSEcCtD
Ticlopidine—Nausea—Thiotepa—hematologic cancer	3.8e-05	0.000226	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	3.8e-05	0.000226	CcSEcCtD
Ticlopidine—Anaphylactic shock—Betamethasone—hematologic cancer	3.78e-05	0.000225	CcSEcCtD
Ticlopidine—Anaphylactic shock—Dexamethasone—hematologic cancer	3.78e-05	0.000225	CcSEcCtD
Ticlopidine—Diarrhoea—Irinotecan—hematologic cancer	3.78e-05	0.000225	CcSEcCtD
Ticlopidine—Diarrhoea—Mitoxantrone—hematologic cancer	3.78e-05	0.000225	CcSEcCtD
Ticlopidine—Vomiting—Carmustine—hematologic cancer	3.78e-05	0.000225	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Etoposide—hematologic cancer	3.76e-05	0.000223	CcSEcCtD
Ticlopidine—Dizziness—Vincristine—hematologic cancer	3.75e-05	0.000223	CcSEcCtD
Ticlopidine—Rash—Carmustine—hematologic cancer	3.75e-05	0.000223	CcSEcCtD
Ticlopidine—Dermatitis—Carmustine—hematologic cancer	3.75e-05	0.000222	CcSEcCtD
Ticlopidine—Vomiting—Alitretinoin—hematologic cancer	3.75e-05	0.000222	CcSEcCtD
Ticlopidine—Headache—Carmustine—hematologic cancer	3.73e-05	0.000221	CcSEcCtD
Ticlopidine—Rash—Alitretinoin—hematologic cancer	3.71e-05	0.000221	CcSEcCtD
Ticlopidine—Dermatitis—Alitretinoin—hematologic cancer	3.71e-05	0.00022	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	3.71e-05	0.00022	CcSEcCtD
Ticlopidine—Thrombocytopenia—Dexamethasone—hematologic cancer	3.71e-05	0.00022	CcSEcCtD
Ticlopidine—Thrombocytopenia—Betamethasone—hematologic cancer	3.71e-05	0.00022	CcSEcCtD
Ticlopidine—Vomiting—Ifosfamide—hematologic cancer	3.7e-05	0.00022	CcSEcCtD
Ticlopidine—Hypersensitivity—Cisplatin—hematologic cancer	3.7e-05	0.00022	CcSEcCtD
Ticlopidine—Headache—Alitretinoin—hematologic cancer	3.69e-05	0.000219	CcSEcCtD
Ticlopidine—Angioedema—Prednisone—hematologic cancer	3.69e-05	0.000219	CcSEcCtD
Ticlopidine—Diarrhoea—Gemcitabine—hematologic cancer	3.68e-05	0.000219	CcSEcCtD
Ticlopidine—Nausea—Thalidomide—hematologic cancer	3.68e-05	0.000218	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—hematologic cancer	3.68e-05	0.000218	CcSEcCtD
Ticlopidine—Dyspepsia—Triamcinolone—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Ticlopidine—Rash—Ifosfamide—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Ticlopidine—Dermatitis—Ifosfamide—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Ticlopidine—Erythema multiforme—Methotrexate—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—hematologic cancer	3.67e-05	0.000218	CcSEcCtD
Ticlopidine—Dizziness—Irinotecan—hematologic cancer	3.66e-05	0.000217	CcSEcCtD
Ticlopidine—Urticaria—Etoposide—hematologic cancer	3.65e-05	0.000217	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—hematologic cancer	3.65e-05	0.000217	CcSEcCtD
Ticlopidine—Body temperature increased—Etoposide—hematologic cancer	3.64e-05	0.000216	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—hematologic cancer	3.63e-05	0.000215	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—hematologic cancer	3.63e-05	0.000215	CcSEcCtD
Ticlopidine—Tinnitus—Methotrexate—hematologic cancer	3.61e-05	0.000215	CcSEcCtD
Ticlopidine—Vomiting—Vincristine—hematologic cancer	3.61e-05	0.000214	CcSEcCtD
Ticlopidine—Anorexia—Betamethasone—hematologic cancer	3.61e-05	0.000214	CcSEcCtD
Ticlopidine—Anorexia—Dexamethasone—hematologic cancer	3.61e-05	0.000214	CcSEcCtD
Ticlopidine—Urticaria—Prednisolone—hematologic cancer	3.6e-05	0.000214	CcSEcCtD
Ticlopidine—Asthenia—Cisplatin—hematologic cancer	3.6e-05	0.000214	CcSEcCtD
Ticlopidine—Rash—Vincristine—hematologic cancer	3.58e-05	0.000213	CcSEcCtD
Ticlopidine—Dermatitis—Vincristine—hematologic cancer	3.58e-05	0.000212	CcSEcCtD
Ticlopidine—Pain—Triamcinolone—hematologic cancer	3.57e-05	0.000212	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—hematologic cancer	3.57e-05	0.000212	CcSEcCtD
Ticlopidine—Headache—Vincristine—hematologic cancer	3.56e-05	0.000211	CcSEcCtD
Ticlopidine—Nausea—Carmustine—hematologic cancer	3.53e-05	0.00021	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—hematologic cancer	3.53e-05	0.000209	CcSEcCtD
Ticlopidine—Vomiting—Irinotecan—hematologic cancer	3.51e-05	0.000209	CcSEcCtD
Ticlopidine—Vomiting—Mitoxantrone—hematologic cancer	3.51e-05	0.000209	CcSEcCtD
Ticlopidine—Nausea—Alitretinoin—hematologic cancer	3.5e-05	0.000208	CcSEcCtD
Ticlopidine—Rash—Irinotecan—hematologic cancer	3.49e-05	0.000207	CcSEcCtD
Ticlopidine—Rash—Mitoxantrone—hematologic cancer	3.49e-05	0.000207	CcSEcCtD
Ticlopidine—Dermatitis—Irinotecan—hematologic cancer	3.48e-05	0.000207	CcSEcCtD
Ticlopidine—Dermatitis—Mitoxantrone—hematologic cancer	3.48e-05	0.000207	CcSEcCtD
Ticlopidine—Headache—Mitoxantrone—hematologic cancer	3.46e-05	0.000206	CcSEcCtD
Ticlopidine—Headache—Irinotecan—hematologic cancer	3.46e-05	0.000206	CcSEcCtD
Ticlopidine—Nausea—Ifosfamide—hematologic cancer	3.46e-05	0.000205	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3.45e-05	0.000205	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3.45e-05	0.000205	CcSEcCtD
Ticlopidine—Arthralgia—Prednisone—hematologic cancer	3.44e-05	0.000204	CcSEcCtD
Ticlopidine—Myalgia—Prednisone—hematologic cancer	3.44e-05	0.000204	CcSEcCtD
Ticlopidine—Diarrhoea—Cisplatin—hematologic cancer	3.43e-05	0.000204	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—hematologic cancer	3.43e-05	0.000204	CcSEcCtD
Ticlopidine—Vomiting—Gemcitabine—hematologic cancer	3.42e-05	0.000203	CcSEcCtD
Ticlopidine—Rash—Gemcitabine—hematologic cancer	3.4e-05	0.000202	CcSEcCtD
Ticlopidine—Dermatitis—Gemcitabine—hematologic cancer	3.39e-05	0.000201	CcSEcCtD
Ticlopidine—Hypersensitivity—Etoposide—hematologic cancer	3.39e-05	0.000201	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—hematologic cancer	3.38e-05	0.000201	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—hematologic cancer	3.37e-05	0.0002	CcSEcCtD
Ticlopidine—Headache—Gemcitabine—hematologic cancer	3.37e-05	0.0002	CcSEcCtD
Ticlopidine—Nausea—Vincristine—hematologic cancer	3.37e-05	0.0002	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—hematologic cancer	3.36e-05	0.000199	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—hematologic cancer	3.36e-05	0.000199	CcSEcCtD
Ticlopidine—Hypersensitivity—Prednisolone—hematologic cancer	3.34e-05	0.000198	CcSEcCtD
Ticlopidine—Dyspepsia—Dexamethasone—hematologic cancer	3.33e-05	0.000198	CcSEcCtD
Ticlopidine—Dyspepsia—Betamethasone—hematologic cancer	3.33e-05	0.000198	CcSEcCtD
Ticlopidine—Urticaria—Triamcinolone—hematologic cancer	3.31e-05	0.000197	CcSEcCtD
Ticlopidine—Asthenia—Etoposide—hematologic cancer	3.3e-05	0.000196	CcSEcCtD
Ticlopidine—Body temperature increased—Triamcinolone—hematologic cancer	3.3e-05	0.000196	CcSEcCtD
Ticlopidine—Anaphylactic shock—Prednisone—hematologic cancer	3.3e-05	0.000196	CcSEcCtD
Ticlopidine—Decreased appetite—Betamethasone—hematologic cancer	3.29e-05	0.000195	CcSEcCtD
Ticlopidine—Decreased appetite—Dexamethasone—hematologic cancer	3.29e-05	0.000195	CcSEcCtD
Ticlopidine—Nausea—Irinotecan—hematologic cancer	3.28e-05	0.000195	CcSEcCtD
Ticlopidine—Nausea—Mitoxantrone—hematologic cancer	3.28e-05	0.000195	CcSEcCtD
Ticlopidine—Pruritus—Etoposide—hematologic cancer	3.25e-05	0.000193	CcSEcCtD
Ticlopidine—Pain—Betamethasone—hematologic cancer	3.24e-05	0.000192	CcSEcCtD
Ticlopidine—Pain—Dexamethasone—hematologic cancer	3.24e-05	0.000192	CcSEcCtD
Ticlopidine—Nausea—Gemcitabine—hematologic cancer	3.2e-05	0.00019	CcSEcCtD
Ticlopidine—Vomiting—Cisplatin—hematologic cancer	3.19e-05	0.00019	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—hematologic cancer	3.17e-05	0.000188	CcSEcCtD
Ticlopidine—Rash—Cisplatin—hematologic cancer	3.16e-05	0.000188	CcSEcCtD
Ticlopidine—Dermatitis—Cisplatin—hematologic cancer	3.16e-05	0.000188	CcSEcCtD
Ticlopidine—Diarrhoea—Etoposide—hematologic cancer	3.15e-05	0.000187	CcSEcCtD
Ticlopidine—Anorexia—Prednisone—hematologic cancer	3.14e-05	0.000187	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—hematologic cancer	3.13e-05	0.000186	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—hematologic cancer	3.11e-05	0.000185	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Dexamethasone—hematologic cancer	3.09e-05	0.000184	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Betamethasone—hematologic cancer	3.09e-05	0.000184	CcSEcCtD
Ticlopidine—Hypersensitivity—Triamcinolone—hematologic cancer	3.07e-05	0.000182	CcSEcCtD
Ticlopidine—Dizziness—Etoposide—hematologic cancer	3.04e-05	0.000181	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—hematologic cancer	3.04e-05	0.00018	CcSEcCtD
Ticlopidine—Urticaria—Dexamethasone—hematologic cancer	3.01e-05	0.000179	CcSEcCtD
Ticlopidine—Urticaria—Betamethasone—hematologic cancer	3.01e-05	0.000179	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Prednisone—hematologic cancer	3e-05	0.000178	CcSEcCtD
Ticlopidine—Dizziness—Prednisolone—hematologic cancer	3e-05	0.000178	CcSEcCtD
Ticlopidine—Asthenia—Triamcinolone—hematologic cancer	2.99e-05	0.000178	CcSEcCtD
Ticlopidine—Body temperature increased—Dexamethasone—hematologic cancer	2.99e-05	0.000178	CcSEcCtD
Ticlopidine—Body temperature increased—Betamethasone—hematologic cancer	2.99e-05	0.000178	CcSEcCtD
Ticlopidine—Nausea—Cisplatin—hematologic cancer	2.98e-05	0.000177	CcSEcCtD
Ticlopidine—Pruritus—Triamcinolone—hematologic cancer	2.95e-05	0.000175	CcSEcCtD
Ticlopidine—Vomiting—Etoposide—hematologic cancer	2.92e-05	0.000174	CcSEcCtD
Ticlopidine—Dyspepsia—Prednisone—hematologic cancer	2.9e-05	0.000172	CcSEcCtD
Ticlopidine—Rash—Etoposide—hematologic cancer	2.9e-05	0.000172	CcSEcCtD
Ticlopidine—Dermatitis—Etoposide—hematologic cancer	2.9e-05	0.000172	CcSEcCtD
Ticlopidine—Headache—Etoposide—hematologic cancer	2.88e-05	0.000171	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—hematologic cancer	2.88e-05	0.000171	CcSEcCtD
Ticlopidine—Myalgia—Methotrexate—hematologic cancer	2.87e-05	0.000171	CcSEcCtD
Ticlopidine—Arthralgia—Methotrexate—hematologic cancer	2.87e-05	0.000171	CcSEcCtD
Ticlopidine—Decreased appetite—Prednisone—hematologic cancer	2.86e-05	0.00017	CcSEcCtD
Ticlopidine—Rash—Prednisolone—hematologic cancer	2.86e-05	0.00017	CcSEcCtD
Ticlopidine—Dermatitis—Prednisolone—hematologic cancer	2.86e-05	0.00017	CcSEcCtD
Ticlopidine—Headache—Prednisolone—hematologic cancer	2.84e-05	0.000169	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—hematologic cancer	2.81e-05	0.000167	CcSEcCtD
Ticlopidine—Dizziness—Triamcinolone—hematologic cancer	2.76e-05	0.000164	CcSEcCtD
Ticlopidine—Anaphylactic shock—Methotrexate—hematologic cancer	2.75e-05	0.000164	CcSEcCtD
Ticlopidine—Nausea—Etoposide—hematologic cancer	2.73e-05	0.000162	CcSEcCtD
Ticlopidine—Asthenia—Dexamethasone—hematologic cancer	2.72e-05	0.000161	CcSEcCtD
Ticlopidine—Asthenia—Betamethasone—hematologic cancer	2.72e-05	0.000161	CcSEcCtD
Ticlopidine—Thrombocytopenia—Methotrexate—hematologic cancer	2.7e-05	0.00016	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Prednisone—hematologic cancer	2.69e-05	0.00016	CcSEcCtD
Ticlopidine—Nausea—Prednisolone—hematologic cancer	2.69e-05	0.00016	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—hematologic cancer	2.69e-05	0.00016	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—hematologic cancer	2.69e-05	0.00016	CcSEcCtD
Ticlopidine—Pruritus—Betamethasone—hematologic cancer	2.68e-05	0.000159	CcSEcCtD
Ticlopidine—Pruritus—Dexamethasone—hematologic cancer	2.68e-05	0.000159	CcSEcCtD
Ticlopidine—Vomiting—Triamcinolone—hematologic cancer	2.65e-05	0.000157	CcSEcCtD
Ticlopidine—Rash—Triamcinolone—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Ticlopidine—Dermatitis—Triamcinolone—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Ticlopidine—Anorexia—Methotrexate—hematologic cancer	2.63e-05	0.000156	CcSEcCtD
Ticlopidine—Urticaria—Prednisone—hematologic cancer	2.62e-05	0.000155	CcSEcCtD
Ticlopidine—Headache—Triamcinolone—hematologic cancer	2.61e-05	0.000155	CcSEcCtD
Ticlopidine—Body temperature increased—Prednisone—hematologic cancer	2.61e-05	0.000155	CcSEcCtD
Ticlopidine—Diarrhoea—Dexamethasone—hematologic cancer	2.59e-05	0.000154	CcSEcCtD
Ticlopidine—Diarrhoea—Betamethasone—hematologic cancer	2.59e-05	0.000154	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—hematologic cancer	2.58e-05	0.000153	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—hematologic cancer	2.52e-05	0.00015	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.51e-05	0.000149	CcSEcCtD
Ticlopidine—Dizziness—Betamethasone—hematologic cancer	2.5e-05	0.000149	CcSEcCtD
Ticlopidine—Dizziness—Dexamethasone—hematologic cancer	2.5e-05	0.000149	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—hematologic cancer	2.49e-05	0.000148	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—hematologic cancer	2.49e-05	0.000148	CcSEcCtD
Ticlopidine—Nausea—Triamcinolone—hematologic cancer	2.48e-05	0.000147	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—hematologic cancer	2.46e-05	0.000146	CcSEcCtD
Ticlopidine—Hypersensitivity—Prednisone—hematologic cancer	2.43e-05	0.000144	CcSEcCtD
Ticlopidine—Dyspepsia—Methotrexate—hematologic cancer	2.42e-05	0.000144	CcSEcCtD
Ticlopidine—Vomiting—Dexamethasone—hematologic cancer	2.41e-05	0.000143	CcSEcCtD
Ticlopidine—Vomiting—Betamethasone—hematologic cancer	2.41e-05	0.000143	CcSEcCtD
Ticlopidine—Decreased appetite—Methotrexate—hematologic cancer	2.39e-05	0.000142	CcSEcCtD
Ticlopidine—Rash—Dexamethasone—hematologic cancer	2.39e-05	0.000142	CcSEcCtD
Ticlopidine—Rash—Betamethasone—hematologic cancer	2.39e-05	0.000142	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—hematologic cancer	2.38e-05	0.000142	CcSEcCtD
Ticlopidine—Dermatitis—Betamethasone—hematologic cancer	2.38e-05	0.000142	CcSEcCtD
Ticlopidine—Dermatitis—Dexamethasone—hematologic cancer	2.38e-05	0.000142	CcSEcCtD
Ticlopidine—Headache—Dexamethasone—hematologic cancer	2.37e-05	0.000141	CcSEcCtD
Ticlopidine—Headache—Betamethasone—hematologic cancer	2.37e-05	0.000141	CcSEcCtD
Ticlopidine—Asthenia—Prednisone—hematologic cancer	2.36e-05	0.00014	CcSEcCtD
Ticlopidine—Pain—Methotrexate—hematologic cancer	2.36e-05	0.00014	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.35e-05	0.000139	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.34e-05	0.000139	CcSEcCtD
Ticlopidine—Pruritus—Prednisone—hematologic cancer	2.33e-05	0.000138	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—hematologic cancer	2.27e-05	0.000135	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—hematologic cancer	2.27e-05	0.000135	CcSEcCtD
Ticlopidine—Diarrhoea—Prednisone—hematologic cancer	2.25e-05	0.000134	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.25e-05	0.000134	CcSEcCtD
Ticlopidine—Nausea—Dexamethasone—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Ticlopidine—Nausea—Betamethasone—hematologic cancer	2.25e-05	0.000133	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—hematologic cancer	2.24e-05	0.000133	CcSEcCtD
Ticlopidine—Pain—Epirubicin—hematologic cancer	2.2e-05	0.000131	CcSEcCtD
Ticlopidine—Urticaria—Methotrexate—hematologic cancer	2.19e-05	0.00013	CcSEcCtD
Ticlopidine—Dizziness—Prednisone—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Ticlopidine—Body temperature increased—Methotrexate—hematologic cancer	2.18e-05	0.000129	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.17e-05	0.000129	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—hematologic cancer	2.11e-05	0.000125	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—hematologic cancer	2.1e-05	0.000125	CcSEcCtD
Ticlopidine—Vomiting—Prednisone—hematologic cancer	2.1e-05	0.000124	CcSEcCtD
Ticlopidine—Rash—Prednisone—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Ticlopidine—Dermatitis—Prednisone—hematologic cancer	2.08e-05	0.000123	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—hematologic cancer	2.07e-05	0.000123	CcSEcCtD
Ticlopidine—Headache—Prednisone—hematologic cancer	2.06e-05	0.000123	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—hematologic cancer	2.05e-05	0.000122	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—hematologic cancer	2.04e-05	0.000121	CcSEcCtD
Ticlopidine—Hypersensitivity—Methotrexate—hematologic cancer	2.03e-05	0.000121	CcSEcCtD
Ticlopidine—Asthenia—Methotrexate—hematologic cancer	1.98e-05	0.000117	CcSEcCtD
Ticlopidine—Nausea—Prednisone—hematologic cancer	1.96e-05	0.000116	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Ticlopidine—Pruritus—Methotrexate—hematologic cancer	1.95e-05	0.000116	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—hematologic cancer	1.9e-05	0.000113	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—hematologic cancer	1.89e-05	0.000113	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—hematologic cancer	1.89e-05	0.000112	CcSEcCtD
Ticlopidine—Diarrhoea—Methotrexate—hematologic cancer	1.88e-05	0.000112	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—hematologic cancer	1.85e-05	0.00011	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Ticlopidine—Dizziness—Methotrexate—hematologic cancer	1.82e-05	0.000108	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—hematologic cancer	1.76e-05	0.000105	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—hematologic cancer	1.76e-05	0.000104	CcSEcCtD
Ticlopidine—Vomiting—Methotrexate—hematologic cancer	1.75e-05	0.000104	CcSEcCtD
Ticlopidine—Rash—Methotrexate—hematologic cancer	1.74e-05	0.000103	CcSEcCtD
Ticlopidine—Dermatitis—Methotrexate—hematologic cancer	1.74e-05	0.000103	CcSEcCtD
Ticlopidine—Headache—Methotrexate—hematologic cancer	1.73e-05	0.000102	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—hematologic cancer	1.71e-05	0.000102	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—hematologic cancer	1.7e-05	0.000101	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—hematologic cancer	1.69e-05	0.0001	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—hematologic cancer	1.64e-05	9.73e-05	CcSEcCtD
Ticlopidine—Nausea—Methotrexate—hematologic cancer	1.64e-05	9.72e-05	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—hematologic cancer	1.63e-05	9.69e-05	CcSEcCtD
Ticlopidine—Rash—Epirubicin—hematologic cancer	1.63e-05	9.65e-05	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—hematologic cancer	1.62e-05	9.64e-05	CcSEcCtD
Ticlopidine—Headache—Epirubicin—hematologic cancer	1.61e-05	9.59e-05	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—hematologic cancer	1.58e-05	9.37e-05	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—hematologic cancer	1.53e-05	9.09e-05	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—hematologic cancer	1.52e-05	9e-05	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—hematologic cancer	1.5e-05	8.93e-05	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—hematologic cancer	1.5e-05	8.92e-05	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—hematologic cancer	1.49e-05	8.87e-05	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—hematologic cancer	1.42e-05	8.41e-05	CcSEcCtD
Ticlopidine—CYP2C19—Metabolism—SDC1—hematologic cancer	4.2e-06	7.11e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—hematologic cancer	4.2e-06	7.1e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TGFB1—hematologic cancer	4.19e-06	7.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.17e-06	7.04e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTR—hematologic cancer	4.16e-06	7.03e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.16e-06	7.03e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.14e-06	6.99e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYCS—hematologic cancer	4.13e-06	6.99e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTR—hematologic cancer	4.12e-06	6.97e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.12e-06	6.97e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	4.11e-06	6.94e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ENO2—hematologic cancer	4.08e-06	6.89e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.06e-06	6.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ENO2—hematologic cancer	4.04e-06	6.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.02e-06	6.79e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NQO1—hematologic cancer	4e-06	6.77e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CD44—hematologic cancer	4e-06	6.77e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.96e-06	6.7e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.96e-06	6.69e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.95e-06	6.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.95e-06	6.68e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.95e-06	6.67e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.92e-06	6.63e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.92e-06	6.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.92e-06	6.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.92e-06	6.63e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—hematologic cancer	3.88e-06	6.56e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—SDC1—hematologic cancer	3.87e-06	6.54e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTP1—hematologic cancer	3.86e-06	6.53e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.86e-06	6.53e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.85e-06	6.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—SDC1—hematologic cancer	3.83e-06	6.48e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.79e-06	6.41e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYCS—hematologic cancer	3.79e-06	6.4e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.77e-06	6.36e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.73e-06	6.31e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NUP98—hematologic cancer	3.73e-06	6.31e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.7e-06	6.25e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.69e-06	6.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.66e-06	6.19e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.66e-06	6.18e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTP1—hematologic cancer	3.64e-06	6.16e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.63e-06	6.13e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.63e-06	6.13e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.62e-06	6.12e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.62e-06	6.12e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.61e-06	6.11e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NUP214—hematologic cancer	3.6e-06	6.08e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.59e-06	6.06e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CA9—hematologic cancer	3.59e-06	6.06e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CD44—hematologic cancer	3.57e-06	6.04e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.57e-06	6.04e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—hematologic cancer	3.57e-06	6.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.56e-06	6.02e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.55e-06	6e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.55e-06	6e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.54e-06	5.99e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.53e-06	5.96e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTR—hematologic cancer	3.52e-06	5.96e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.52e-06	5.96e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.5e-06	5.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.46e-06	5.84e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ENO2—hematologic cancer	3.46e-06	5.84e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—hematologic cancer	3.45e-06	5.83e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ABCB1—hematologic cancer	3.45e-06	5.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.39e-06	5.73e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.38e-06	5.72e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.37e-06	5.7e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.36e-06	5.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.35e-06	5.66e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTM1—hematologic cancer	3.35e-06	5.66e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—NCOR1—hematologic cancer	3.35e-06	5.66e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.34e-06	5.65e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.34e-06	5.64e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.34e-06	5.64e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—TXN—hematologic cancer	3.34e-06	5.64e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.3e-06	5.58e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—hematologic cancer	3.3e-06	5.58e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CD44—hematologic cancer	3.29e-06	5.56e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.29e-06	5.56e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.28e-06	5.54e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.26e-06	5.52e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CD44—hematologic cancer	3.26e-06	5.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.26e-06	5.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.23e-06	5.46e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.2e-06	5.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.19e-06	5.39e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.16e-06	5.34e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—hematologic cancer	3.16e-06	5.34e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.14e-06	5.3e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.14e-06	5.3e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.13e-06	5.29e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.11e-06	5.26e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.09e-06	5.22e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.09e-06	5.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYCS—hematologic cancer	3.08e-06	5.21e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.07e-06	5.19e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.07e-06	5.19e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.06e-06	5.18e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.05e-06	5.16e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.05e-06	5.16e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.02e-06	5.11e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.98e-06	5.04e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.97e-06	5.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MTHFR—hematologic cancer	2.96e-06	5e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.95e-06	4.99e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—hematologic cancer	2.91e-06	4.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.88e-06	4.88e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.88e-06	4.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.82e-06	4.77e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.8e-06	4.72e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.8e-06	4.72e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CD44—hematologic cancer	2.79e-06	4.71e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NQO1—hematologic cancer	2.79e-06	4.71e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.78e-06	4.69e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.76e-06	4.66e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.74e-06	4.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.74e-06	4.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.74e-06	4.63e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.73e-06	4.61e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTR—hematologic cancer	2.72e-06	4.6e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.72e-06	4.6e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.72e-06	4.59e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.71e-06	4.59e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.69e-06	4.55e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.67e-06	4.51e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.64e-06	4.46e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.64e-06	4.45e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.63e-06	4.45e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.62e-06	4.43e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.61e-06	4.41e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.6e-06	4.39e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.59e-06	4.37e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.57e-06	4.35e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.53e-06	4.27e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.52e-06	4.26e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.52e-06	4.26e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.5e-06	4.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.5e-06	4.22e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.5e-06	4.22e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.49e-06	4.2e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.44e-06	4.13e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.42e-06	4.09e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.39e-06	4.04e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.37e-06	4e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.36e-06	3.98e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ALB—hematologic cancer	2.34e-06	3.95e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.32e-06	3.93e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.32e-06	3.92e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.31e-06	3.9e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ALB—hematologic cancer	2.29e-06	3.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.28e-06	3.85e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.25e-06	3.8e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.23e-06	3.78e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.23e-06	3.76e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.21e-06	3.73e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.2e-06	3.72e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.19e-06	3.7e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.19e-06	3.69e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALB—hematologic cancer	2.16e-06	3.65e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CD44—hematologic cancer	2.15e-06	3.63e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.15e-06	3.63e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.13e-06	3.61e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.13e-06	3.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.13e-06	3.61e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.11e-06	3.57e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.06e-06	3.49e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.03e-06	3.44e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.03e-06	3.44e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.02e-06	3.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2e-06	3.39e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALB—hematologic cancer	1.98e-06	3.34e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.95e-06	3.29e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.9e-06	3.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.89e-06	3.2e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.89e-06	3.19e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.89e-06	3.19e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.87e-06	3.16e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.86e-06	3.14e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.79e-06	3.03e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.79e-06	3.02e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.78e-06	3.01e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALB—hematologic cancer	1.77e-06	2.98e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.75e-06	2.95e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PTEN—hematologic cancer	1.75e-06	2.95e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.73e-06	2.93e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.72e-06	2.91e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—EP300—hematologic cancer	1.7e-06	2.87e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.7e-06	2.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.69e-06	2.85e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—EP300—hematologic cancer	1.67e-06	2.81e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.66e-06	2.81e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.65e-06	2.78e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.65e-06	2.78e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PTEN—hematologic cancer	1.65e-06	2.78e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.78e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.63e-06	2.76e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALB—hematologic cancer	1.62e-06	2.74e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALB—hematologic cancer	1.61e-06	2.72e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.59e-06	2.68e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—EP300—hematologic cancer	1.57e-06	2.65e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.56e-06	2.63e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.63e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.54e-06	2.6e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.51e-06	2.55e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.47e-06	2.48e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.46e-06	2.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—EP300—hematologic cancer	1.44e-06	2.43e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.43e-06	2.42e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.42e-06	2.4e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.39e-06	2.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALB—hematologic cancer	1.38e-06	2.33e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.35e-06	2.28e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.32e-06	2.22e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—EP300—hematologic cancer	1.28e-06	2.17e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.26e-06	2.13e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.24e-06	2.09e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.23e-06	2.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.23e-06	2.08e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.22e-06	2.07e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.21e-06	2.05e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—EP300—hematologic cancer	1.18e-06	2e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—EP300—hematologic cancer	1.17e-06	1.98e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.16e-06	1.96e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.13e-06	1.92e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.08e-06	1.82e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.06e-06	1.8e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALB—hematologic cancer	1.06e-06	1.79e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PTEN—hematologic cancer	1.05e-06	1.77e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.03e-06	1.74e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.02e-06	1.72e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—hematologic cancer	1.01e-06	1.7e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—EP300—hematologic cancer	1e-06	1.69e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.5e-07	1.61e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—hematologic cancer	9.49e-07	1.6e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.37e-07	1.58e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.74e-07	1.48e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—hematologic cancer	8.7e-07	1.47e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.67e-07	1.46e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PTEN—hematologic cancer	8.1e-07	1.37e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—hematologic cancer	7.76e-07	1.31e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—EP300—hematologic cancer	7.73e-07	1.31e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.4e-07	1.25e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—hematologic cancer	7.14e-07	1.21e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—hematologic cancer	7.08e-07	1.2e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—hematologic cancer	6.05e-07	1.02e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.71e-07	9.66e-06	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.67e-07	7.89e-06	CbGpPWpGaD
